Eventide Asset Management - TRACON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$3,015,000
+6.3%
900,0000.0%0.16%
-2.5%
Q3 2017$2,835,000
+31.2%
900,0000.0%0.16%
+20.1%
Q2 2017$2,160,000
-36.0%
900,0000.0%0.13%
-39.9%
Q1 2017$3,375,000
-20.4%
900,000
+4.0%
0.22%
-19.2%
Q4 2016$4,241,000
+21.2%
865,526
+67.2%
0.28%
+29.0%
Q3 2016$3,500,000
+54.3%
517,7000.0%0.21%
+54.0%
Q2 2016$2,268,000
-37.3%
517,7000.0%0.14%
-31.2%
Q1 2016$3,619,000
-24.4%
517,7000.0%0.20%
-15.5%
Q4 2015$4,784,000
+21.2%
517,700
+28.2%
0.24%
+4.4%
Q3 2015$3,946,000403,9120.23%
Other shareholders

There were no reported owners of TRACON PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of TRACON PHARMACEUTICALS INC shareholders